USE OF OLFACTORY RECEPTOR OR13A1 ANTAGONISTS IN THE TREATMENT OF LYMPHOMAS Application WO-2023169996-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2023
USE OF OLFACTORY RECEPTOR OR13A1 LIGANDS IN THE TREATMENT OF LYMPHOMAS Application EP-4241766-A1 European Patent Office 13 Sep 2023
Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds for the treatment of pancreatic… Grant US-11655214-B2 United States of America 23 May 2023
Vaccino a DNA per l’uso nel trattamento profilattico o terapeutico dell’adenocarcinoma… N/A IT-202100024779-A1 Italy 28 Mar 2023